Helix Biomedix Raises $3.2M

Luke Timmerman2/13/09

Helix BioMedix, a Bothell, WA-based developer of peptide molecules, said it has raised $3.2 million through debt that can convert into shares of stock, plus warrants to buy its stock. The company (OTCBB: HXBM) plans to use the money for general corporate purposes, and to continue expanding its consumer program. The company’s peptides can be found in skin care and other cosmetic products.

Luke Timmerman is the National Biotech Editor of Xconomy. E-mail him at ltimmerman@xconomy.com Follow @